Company Filing History:
Years Active: 2009
Title: Yuxian He: Innovator in Monoclonal Antibody Research
Introduction
Yuxian He is a notable inventor based in the Bronx, NY (US). He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His work focuses on combating severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
Latest Patents
Yuxian He holds a patent for "Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus." This invention provides an isolated antibody capable of binding to the receptor-binding domain of the spike protein of SARS-CoV. The antibody competitively inhibits the binding of SARS-CoV to host cells. The applications of this invention include: 1) passive-immunizing agents for the prevention of SARS-CoV infection; 2) biological reagents for the diagnosis of SARS-CoV infection; 3) immunotherapeutics for early treatment of SARS-CoV infection; and 4) probes for studying the immunogenicity, antigenicity, structure, and function of the SARS-CoV S protein. He has 1 patent to his name.
Career Highlights
Yuxian He is currently associated with the New York Blood Center, Inc., where he continues to advance his research in antibody development. His work has been instrumental in understanding and addressing viral infections.
Collaborations
Yuxian He collaborates with Shibo Jiang, who is also involved in research related to monoclonal antibodies. Their partnership enhances the potential for innovative solutions in combating viral infections.
Conclusion
Yuxian He is a prominent inventor whose work in monoclonal antibodies has significant implications for public health. His contributions to the field of immunology are paving the way for new therapeutic approaches to viral infections.